FDA approves CT LUCIA 621P Monofocal IOL from ZEISS
The U.S. Food and Drug Administration (FDA) has approved the CT LUCIA 621P Monofocal IOL, an aspheric, monofocal, single-piece C-loop IOL, according to a press release. This IOL features the patented ZEISS Optic Asphericity Concept, which compensates for a wide range of spherical aberrations, optimizing visual outcomes in the event of potential decentration and lens misalignments.
The CT LUCIA 621P Monofocal IOL is a part of the ZEISS cataract workflow solution portfolio, which helps surgeons provide optimized visual outcomes for cataract patients. The IOL comes in a fully preloaded injector, enabling an intuitive, smooth, and controlled injection. The IOL’s architecture is designed to enable easy centering while maximizing direct capsular contact, ensuring stability and supporting a consistent position in the bag.
With the FDA’s approval, the CT LUCIA 621P Monofocal IOL is now available for use in the United States.
Stay Connected! Join Our Newsletter
Contact
Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809
+908-505-8899
[email protected]